Zhengye Biotechnology Holding (ZYBT) Construction in Progress (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Construction in Progress of $86005.5 for Q4 2025, down 93.67% year-over-year from $1.4 million in Q4 2024, and down 93.67% quarter-over-quarter from $1.4 million in Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Construction in Progress (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Construction in Progress for 3 consecutive years, with $86005.5 the latest figure, recorded in Q4 2025.
- In Q4 2025, Construction in Progress fell 93.67% year-over-year to $86005.5; the TTM figure through Dec 2025 stood at $86005.5 (down 93.67% YoY), while the FY2025 annual figure was $87000.0, down 93.49% from the prior year.
- Construction in Progress slipped to $86005.5 in Q4 2025 per ZYBT's latest filing, from $1.4 million in the prior quarter.
- Across five years, Construction in Progress topped out at $1.4 million in Q4 2024 and bottomed at $86005.5 in Q4 2025.
- Historically, Construction in Progress has averaged $833801.2 across 3 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2024 — Construction in Progress rose 28.35% — and 2025, when it slumped 93.67%.
- Zhengye Biotechnology Holding's Construction in Progress stood at $1.1 million in 2023, then rose by 28.35% to $1.4 million in 2024, then plunged by 93.67% to $86005.5 in 2025.
- Business Quant data shows ZYBT's Construction in Progress at $86005.5 in Q4 2025, $1.4 million in Q4 2024, and $1.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 77.91 Mn | - | 86,005.49 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 86,005.49 |
| Dec 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.06 Mn |